Meeting
2023 ASCO Annual Meeting
Gender disparities in metastatic RCC therapies and outcomes.
Authors
Olivia French Gordon
George Washington University Hospital, Washington, DC
Olivia French Gordon , Romtin Nadjafi , Vincent Xu , Arthur Drouaud , Michael Joseph Whalen , Yifeng Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4565)
DOI
10.1200/JCO.2023.41.16_suppl.4565
Abstract #
4565
Poster Bd #
57
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Linear muscle segmentation for metastatic renal cell carcinoma.
First Author: Edouard Nicaise
Poster
2023 ASCO Annual Meeting
Gender and postoperative surgical margin status in MIBC: An analysis of the National Cancer Database.
First Author: Olivia French Gordon
Poster
2023 ASCO Genitourinary Cancers Symposium
Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).
First Author: Sally Leong
Poster
2022 ASCO Genitourinary Cancers Symposium
Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).
First Author: Vishal Navani